References
- Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Cherin P. Antisynthetase syndrome. Joint Bone Spine 2003;70:161–8.
- Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, . A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70:360–74.
- Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, . Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 2009;60:2183–92.
- Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D, . Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 2008; 63:53–9.
- Kotani T, Makino S, Takeuchi T, Kagitani M, Shoda T, Hata A, . Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. J Rheumatol 2008;35:254–9.
- Sem M, Molberg O, Lund MB, Gran JT. Rituximab treatment of the anti-synthetase syndrome: a retrospective case series. Rheumatology (Oxford) 2009;48:968–71.
- Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 2005;52:2439–46.
- Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO, . The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart–Lung Transplantation Report – 2009. J Heart Lung Transplant 2009;28:1031–49.
- Gasper WJ, Sweet MP, Golden JA, Hoopes C, Leard LE, Kleinhenz ME, . Lung transplantation in patients with connective tissue disorders and esophageal dysmotility. Dis Esophagus 2008;21:650–5.
- Yousem SA, Gibson K, Kaminski N, Oddis CV, Ascherman DP. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Mod Pathol 2010;23:874–80.